CBT Cabot Corporation
$79.68▲ +1.13%
Materials
Other
After hours
$79.68▼ -0.09%
Sep 11, 4:01 PM ET
Volume 382.1K
Avg Volume (10D) 324.7K
Key Metrics & Fundamentals
Market Cap
$4.11B
P/E Ratio
22.3
Div Yield
2.34%
52W Range
58.33 - 94.53
% vs 50 MA
-8.48%
% vs 200 MA
1.19%
RSI-14
33.7
MACD Histogram
-0.4100
Beta (1Y vs SPY)
0.60
Free Cash Flow
$37.00M
Gross Rev
$982.00M
Gross Profit
$184.00M
EBITDA
$126.00M
COGS
$798.00M
Operating Exp
$86.00M
Operating Income
$98.00M
EBIT
$98.00M
Pretax Income
$58.00M
Net Income
$6.00M
EPS (Diluted)
0.12
Price & Volume History
Loading chart…
Recent News
Cabot Stock Rallies 17% in 6 Months: Here's What's Driving the Upside
Zacks · Sep 9, 2026 3:58 PM
Why Is Cabot (CBT) Down 1.6% Since Last Earnings Report?
Zacks · Sep 2, 2026 3:30 PM
Reasons Why You Should Retain Cabot Stock in Your Portfolio Now
Zacks · Sep 2, 2026 1:54 PM
Cabot Wealth Management Becomes First Customer to Leverage Ridgeline Intelligent Outcomes
GlobeNewswire · Sep 1, 2026 12:00 PM
Cabot Corporation Prices $350 Million 4.950% Senior Notes Due 2029
GlobeNewswire · Aug 12, 2026 9:35 PM
Cabot (CBT) Q3 2026 Earnings Call Transcript
Motley Fool · Aug 11, 2026 1:29 AM
CBT Q3 Earnings Beat Estimates on Performance Chemicals Strength
Zacks · Aug 10, 2026 2:31 PM
UBS Adjusts Price Target on Cabot to $92 From $97, Maintains Neutral Rating
MT Newswires · Aug 5, 2026 1:17 PM
Cabot Q3 Earnings Call Highlights
MarketBeat · Aug 4, 2026 9:03 PM
Cabot Corp (CBT) (Q3 2026) Earnings Call Highlights: Strong Performance Chemicals Growth and ...
GuruFocus.com · Aug 4, 2026 7:03 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See CBT's money flow as a full page
Social Sentiment
Avg -0.30 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.